source
- AI tools struggle to improve emergency room workflow, study findsThe article notes that CEOs of leading AI firms have promised dramatic health benefits, but real‑world testing in emergency departments tells a different story. At Brigham and Women’s Hospital, th…
- Evommune's MRGPRX2 antagonist fails second Phase 2b trial in atopic dermatitisEvommune reported that its experimental small-molecule antagonist of the MRGPRX2 receptor did not meet its primary endpoints in a Phase 2b study in patients with atopic dermatitis. The study, cond…